U2.1.1 ANTIMICROBIALS Flashcards
Substances that inhibit, kill or
destroy microorganisms
Antimicrobial Agents
Examples of antimicrobial agents
Antibiotics, Antibacterial Agent, Antiviral, Anti-fungal, Anti-parasitic
Sources of Antimicrobial Agents
- Microorganisms Bacteria or Fungi
- Chemically Synthesized
Determine the Spectrum of Action
wide spectrum of action
Broad Spectrum
Determine the Spectrum of Action
limited spectrum of action
Narrow Spectrum
Determine the Spectrum of Action
Penicillin G, Bacitracin, Clindamycin, Erythromycin, Polymyxin B, Vancomycin
Narrow Spectrum
Determine the Spectrum of Action
Action against Gr (+) and Gr (-) bacteria
Broad Spectrum
Determine the Spectrum of Action
Tetracycline, Ampicillin, Cephalosporins
Broad Spectrum
According to Action
Kill or destroy the microorganism
Bacteriocidal Agents
Determine the Spectrum of Action
Disadvantage: Destruction/Inhibition of the normal flora leading to superinfections
Broad Spectrum
According to Action
Used ni life threatening infections and in infections in
immunosuppressed patients
Bacteriocidal Agents
According to Action
Inhibits the growth of microorganisms
Bacteriostatic Agents
According to Action
Chloramphenicol
- Erythromycin, Clindamycon, Sulfonamides, Trimethoprim, Tetracyclines, Tigecycline, Linezolid, Quinupristin
Bacteriostatic
According to Action
Aminoglycosides
- B-lactams, Vancomycin, Daptomycin, Teicoplanin, Telavancin, Quinolones, Rifampin, Metronidazole
Bactericidal
Actions of Antimicrobial Drugs (Cell wall/ Cell membrane/ 50S Inhibitors/ 30S Inhibitors/ Nucleic Acid Synthesis)
B-lactams, Penicillins, Cephalosporins, Vancomycin
For cell wall
Actions of Antimicrobial Drugs (Cell wall/ Cell membrane/ 50S Inhibitors/ 30S Inhibitors/ Nucleic Acid Synthesis)
Polymyxins
Cell membrane
Actions of Antimicrobial Drugs (Cell wall/ Cell membrane/ 50S Inhibitors/ 30S Inhibitors/ Nucleic Acid Synthesis)
Erythromycin, Clindamycin, Chloramphenicol, Oxazolidinone-linezolid, Streptogramine-DQ
50S Inhibitors
Actions of Antimicrobial Drugs (Cell wall/ Cell membrane/ 50S Inhibitors/ 30S Inhibitors/ Nucleic Acid Synthesis)
Aminoglycosides, Tetracyclines, Glycylcycline-tigecydine
30S Inhibitors
Actions of Antimicrobial Drugs (Cell wall/ Cell membrane/ 50S Inhibitors/ 30S Inhibitors/ Nucleic Acid Synthesis)
Nalidixic Acid, Fluoroquinolones, Rifampin
DNA synthesis : Nalidixic Acid, Fluoroquinolones
RNA polymerase : Rifampin
Inhibition of Cell Wall Synthesis
Inhibits cell wall synthesis by binding enzymes involved in peptidoglycan production
B-lactams
Inhibition of Cell Wall Synthesis
Both gram-pos and gram-neg bacteria but spectrum may vary with the individual antibiotic
B-lactams
Inhibition of Cell Wall Synthesis
proteins involved in peptidoglycan production
PBPs - Penicillin-binding proteins
Inhibition of Cell Wall Synthesis
MOA: Inhibition of Enzymes needed for peptidoglycan formation
Beta Lactam Drugs
Inhibition of Cell Wall Synthesis - Beta Lactam Drugs
from Penicillium notatum
Penicilin
Inhibition of Cell Wall Synthesis - Beta Lactam Drugs
Ampicillin, amoxicillin
Aminopenicillins
Inhibition of Cell Wall Synthesis - Beta Lactam Drugs
Methicillin, Oxacillin, Nafcillin
Penicillinase Resistant Penicillins
Inhibition of Cell Wall Synthesis - Beta Lactam Drugs
Aminopenicillins (ampicillin, amoxicillin), Carboxypenicillin (carbenicillin, ticarcillin), Acycalmminopenicillins, Ureidopenicillins
Extended Spectrum Penicillin
Inhibition of Cell Wall Synthesis - Beta Lactam Drugs
augmentin, Pip-Taz, ampicillin/sulbactam
Penicillin Co-drugs
Inhibition of Cell Wall Synthesis - Beta Lactam Drugs
source Acremonium
Cephalosporins
Inhibition of Cell Wall Synthesis - Beta Lactam Drugs
Structurally Similar to penicillin but better able to withstand B-lactamase and more modifiable
Cephalosporins
Inhibition of Cell Wall Synthesis - Beta Lactam Drugs
original cephalosporin, modified to aminocephalosporanic acid
Cephalosporin C
Inhibition of Cell Wall Synthesis - Beta Lactam Drugs
Spectrum of Cephalosporins
1st Gen - Narrow Spectrum
2nd Gen - Expanded Spectrum
3rd Gen - Broad Spectrum
4th Gen - Extended Spectrum
Inhibition of Cell Wall Synthesis - Beta Lactam Drugs
Narrow Spectrum, Aztreonam
Monobactams
Inhibition of Cell Wall Synthesis - Beta Lactam Drugs
Imipinem, meropenem, doripenem, ertapenem
Carbapanems
Inhibition of Cell Wall Synthesis - Beta Lactam Drugs
- Broad Spectrum (similar to 3rd generation cephalosporins, slightly greater activity against enterics, Pseudomonas, and anaerobes
- Not effective for MRSA and VRE
Carbapanems
Inhibition of Cell Wall Synthesis
MOA: Binds to terminal D-Ala-D-Ala of the pentapeptidyl-glycosyl peptidoglycan intermediates
Glycopeptides
Inhibition of Cell Wall Synthesis
Vancomycin, dalbavancin, teicoplamin
GLYCOPEPTIDES
Inhibition of Cell Wall Synthesis
Activity is limited to Gram Positive Organisms Only
Glycopeptides
Inhibition of Cell Wall Synthesis
- MOA: inhibit the synthesis of the peptidoglycan precursors in the cytoplasm
- 2nd line drug for TB
Cycloserine
Inhibitors of Cell Membrane Function (Disruption of Cell Membrane)
- Polymyxin B and Polymyxin E (Colistin)
- Cyclic Polypeptides
Polymyxins
Inhibitors of Cell Membrane Function (Disruption of Cell Membrane)
Source: Bacillus licheniformis
Bacitracin
Inhibitors of Cell Membrane Function (Disruption of Cell Membrane)
- MOA: Inhibits the transport of lipid-bound precursors across the cytoplasmic membrane
- Toxic; limited to topical application
Bacitracin
Inhibitors of Cell Membrane Function (Disruption of Cell Membrane)
- MOA : Act like detergents which interact with phospholipids, increasing permeability
- Agent of last resort to P. aeruginosa and Acinetobacter infections
- Toxic (neurotoxic and nephrotoxic)
Polymyxins
Inhibitors of Cell Membrane Function (Disruption of Cell Membrane)
- Disrupt membranes of Gr (+) bacteria
- For VRSA,VRE, MRSA
- Daptomycins
Lipopeptides
Inhibition of Folate Synthesis
Enzymes mediating folate synthesis
Dihydropteroate synthase & Dihydrofolate reductase
Inhibition of Folate Synthesis
is an important precursor in DNA synthesis of bacteria
Folate
Inhibition of Folate Synthesis
MOA: competitive inhibition of folic acid synthesis. Binding to dihydropteroate synthase (analogue PABA)
Sulfonamides
Inhibition of Folate Synthesis
- Moderately Toxic: vomiting, nausea, hypersensitivity reactions
- Can be antagonistic to certain medications (warfarin, phenytoin, oral hypoglycemic agents)
Sulfonamides
Inhibition of Folate Synthesis
MOA: blocks the step leading to formation tetrahydrofolate by preventing dihydrofolate reductase mediated recycling of folate coenzymes
Trimetroprim
Inhibition of DNA Synthesis
MOA: bind and interfere with DNA gyrase and Topoisomerase IV
Fluoroquinolones
Inhibition of DNA Synthesis
- Toxicity: Tendinitis; rupture of Achilles tendon
- Ex. Nalidixic Acid
- For Enterics, pseudomonads, Staphylococus, Streptococcus, Neisseria
Fluoroquinolones
Interference with DNA Synthesis
MOA: Nitro group is reduced by nitroreductase leading to generation of cytotoxic compounds and free radicals that disrupt DNA that leads to bactericidal effect
Metronidazole
Interference with DNA Synthesis
- Effective in Anaerobic environments
- For: Anaerobes, microaerophiles, protozoans, Gardnerella, C. difficile
Metronidazole
Interference with RNA Synthesis
MOA: binds to DNA dependent RNA polymerase to inhibit RNA synthesis
Rifamycins such as Rifamin/ Rifampicin
Interference with RNA Synthesis
Primarily for Gram (+) Organisms; 1st line of treatment for TB, prophylaxis for N. meningitidis carriers; intracellular pathogens
Rifamycins such as Rifamin/ Rifampicin
Inhibits 50S Ribosome
- Broad Spectrum
- Toxic: Aplastic Anemia, Gray Baby Syndrome
Chloramphenicol
Inhibits 50S Ribosome
MOA: inhibits translation through inhibition of elongation step; preventing attachment of AA
Chloramphenicol
Inhibits 50S Ribosome
MOA: inhibits protein synthesis by binding to 23s RNA of the 50s ribosomal subunit inhibiting transfer RNA
Macrolides
Inhibits 50S Ribosome
- Clindamycin, Erythromycin
- Mostly bacteriostatic
- For Intracellular pathogens (can penetrate WBCs), Gr (+), Mycoplasma, Treponemes and Rickettsia
Macrolides
Inhibits 50S Ribosome
- Linezolid
- Gr (+) and Mycobacteria
Oxazolidinones (synthetic)
Inhibits 30s Ribosome
MOA: Inhibits protein synthesis by binding reversibly to the 30s ribosomal subunit
Tetracycline and Doxycycline
Inhibits 30s Ribosome
Broad spectrum; bacteriostatic; also for intracellular pathogens, Mycoplasma, Spirochetes, Shigella
Tetracycline and Doxycycline
Inhibits 30s Ribosome
Toxicity:
* GI irritation
* Phototoxic dermatitis
* Toxic to liver and kidney; phototoxic
* Discolored teeth and depressed bone growth
Tetracycline and Doxycycline
Inhibits 30s ribosome
- Often used together with penicillins in order to diffuse and enter bacterial cell
- Narrow Therapeutic Index
Aminoglycosides
Inhibits 30s ribosome
- Ex. Streptomycin, gentamicin, tobramycin, amikacin, neomycin
- Toxicity: Ototoxic, nephrotoxic
Aminoglycosides
Antimycobacterial Agents
1st line drugs
Isoniazid, Rifampicin, Pyrazinamide
Antimycobacterial Agents
2nd line drugs
Ethambutol, Streptomycin
Antimycobacterial Agents : 1st Line Drugs
interferes with formation of mycolic acid
Isoniazid
Antimycobacterial Agents : 1st Line Drugs
inhibit DNA dependent RNA polymerase
Rifampicin
Antimycobacterial Agents : 1st Line Drugs
Bactericidal
Pyrazinamide
Antimycobacterial Agents : 2nd Line Drugs
inhibit mycolic acid
Ethambutol
Antimycobacterial Agents : 2nd Line Drugs
aminoglycoside
Streptomycin
Composed of a beta-lactam drug with antimicrobial activity and a beta lactam drug without activity
Beta-Lactam combinations
Effective against organisms that produce beta lactamases that are bound by the inhibitor
Beta-Lactam combinations
Examples of Beta-Lactam combinations
- Ampicillin-sulbactam
- Amoxicillin-clavulanic acid
- Piperacillin-tazobactam
Mechanism of Antibiotic Resistance
Changes that result in observably reduced susceptibility of an organism to a particular antimicrobial agent
Biologic Resistance
Mechanism of Antibiotic Resistance
- Antimicrobial susceptibility has been lost
- Drug is no longer effective for clinical use
Clinical Resistance
Mechanism of Antibiotic Resistance
- random mutation due to certain agent
Environmentally Mediated Antimicrobial Resistance
Environmentally Mediated Antimicrobial Resistance
decreased pH leads to aminoglycoside and erythromycin resistance; acidic
pH
Environmentally Mediated Antimicrobial Resistance
Increased pH leads to tetracycline resistance; alkaline
pH
Environmentally Mediated Antimicrobial Resistance
Decreased activity of aminoglycosides
Anaerobic Environment
Environmentally Mediated Antimicrobial Resistance
Decreased activity of aminoglycosides to P. aeruginosa
Mg and Ca Conc.
Environmentally Mediated Antimicrobial Resistance
Decreased activity of sulfonamide and
trimethoprim against enterococci
Folate metabolites
Types of Microorganism-Mediated Antimicrobial Resistance
- Intrinsic : inherent resistance
- Acquired
Mechanisms of Intrinsic Resistance
Sessile bacterial communities
Biofilms
Mechanisms of Intrinsic Resistance
Irreversibly attached to solid surfaces
Biofilms
Mechanisms of Intrinsic Resistance
Embedded in exopolysaccharide matrix
Biofilms
Type of Resistance
Resistance of S. saprophyticus to Novobiocin
Intrinsic Resistance
Type of Resistance
Resistance of Proteus, Providencia, Morganella and Edwardsiella to Polymyxins
Intrinsic Resistance
Type of Resistance
- Occurs as a result of prior exposure
- Caused by changes ni the genetic make up
Acquired Resistance
Type of Resistance
Genetically Encoded via:
- successful genetic mutation
- Acquisition of genes via gene transfer
- Combination of mutational and gene transfer
Acquired Resistance
Acquired Resistance
Changes in the genes coding for the efflux pump
Efflux
Acquired Resistance : Efflux gene
in Streptococcus pneumonia leading to macrolide resistance
mefA gene
Acquired Resistance : Efflux gene
S. aureus and Enterococcus against macrolides
mrsA gene
Acquired Resistance : Efflux gene
S.agalactiae against macrolides
mreA gene